aspirin has been researched along with ridogrel in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 13 (86.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosio, G; Chiariello, M; Golino, P; Pascucci, I; Ragni, M; Russolillo, E | 1 |
| Abbas, NA; Hirschelmann, R; Mest, HJ; Taube, C | 1 |
| Lumley, P; Watts, IS; Wharton, KA; White, BP | 1 |
| Beetens, J; De Clerck, F; Janssen, PA; Loots, W; Somers, Y; Wouters, L; Wynants, J | 1 |
| Arnout, J; Deckmyn, H; Hoet, B; Vermylen, J | 1 |
| Anderson, HV; Buja, LM; De Clerck, F; Golino, P; NcNatt, JM; Rosolowsky, M; Willerson, JT; Yao, SK | 1 |
| Arnout, J; De Reys, S; Deckmyn, H; Falcon, C; Hoet, B; Vermylen, J | 1 |
| Arnout, J; Hoet, B; Vermylen, J | 1 |
| Colombo, M; Dho, L; Pierucci, L; Rosa, B; Salvati, P; Ukmar, G; Vaghi, F; Volpi, D | 1 |
| Pileggi, F; Tranchesi, B; Van de Werf, F; Vercammen, E; Verstraete, M | 1 |
| Faili, A; Hatmi, M; Randon, J; Vargaftig, BB | 1 |
| Ambrosio, G; Chiariello, M; Condorelli, M; de Clerk, F; Focaccio, A; Golino, P; Pace, L; Ragni, M; Villari, B | 1 |
| Berens, ME; Djawaheri, J; Giese, A; Hagel, C; Kim, EL; Westphal, M; Zapf, S | 1 |
| Bhatt, DL; Meadows, TA | 1 |
2 review(s) available for aspirin and ridogrel
| Article | Year |
|---|---|
Pharmacological manipulation of the thromboxane pathway in blood platelets.
Topics: Animals; Antithrombins; Aspirin; Blood Platelets; Epoprostenol; Humans; Imidazoles; Pentanoic Acids; Platelet Activation; Pyridines; Thromboxane-A Synthase | 1990 |
Clinical aspects of platelet inhibitors and thrombus formation.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine | 2007 |
4 trial(s) available for aspirin and ridogrel
| Article | Year |
|---|---|
R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin.
Topics: Aspirin; Bleeding Time; Blood Platelets; Cyclic AMP; Dose-Response Relationship, Drug; Double-Blind Method; Humans; In Vitro Techniques; Pentanoic Acids; Phosphoproteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane B2; Thromboxane-A Synthase; Valerates | 1990 |
R68070, a combined thromboxane/endoperoxide receptor antagonist (TRA) and thromboxane synthase inhibitor (TSI), prolongs the bleeding time more than aspirin in man.
Topics: Aspirin; Bleeding Time; Blood Platelets; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Humans; In Vitro Techniques; Male; Pentanoic Acids; Prostaglandins; Pyridines; Random Allocation; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane-A Synthase; Valerates | 1989 |
Ridogrel does not increase the speed and rate of coronary recanalization in patients with myocardial infarction treated with alteplase and heparin.
Topics: Aspirin; Coronary Angiography; Drug Therapy, Combination; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Pentanoic Acids; Pyridines; Thrombolytic Therapy; Thromboxane-A Synthase; Time Factors; Tissue Plasminogen Activator | 1994 |
Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspir
Topics: Aged; Aspirin; Coronary Angiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pentanoic Acids; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Thrombolytic Therapy; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Treatment Outcome; Vascular Patency | 1994 |
9 other study(ies) available for aspirin and ridogrel
| Article | Year |
|---|---|
Experimental carotid stenosis and endothelial injury in the rabbit: an in vivo model to study intravascular platelet aggregation.
Topics: Animals; Arachidonic Acid; Aspirin; Carotid Stenosis; Disease Models, Animal; Endothelium, Vascular; Female; Male; Pentanoic Acids; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Pyridines; Rabbits; Thromboxane-A Synthase | 1992 |
Thromboxane plasma level in kappa-carrageenin-induced acronecrosis of the tail in rats.
Topics: Animals; Aspirin; Carrageenan; Chlorpromazine; Dexamethasone; Heparin; Imidazoles; Naphthalenes; Necrosis; Pentanoic Acids; Pyridines; Radioimmunoassay; Rats; Rats, Inbred Strains; Thromboxane A2; Thromboxane B2 | 1991 |
Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Topics: Aspirin; Biphenyl Compounds; Drug Interactions; Fatty Acids, Monounsaturated; Heptanoic Acids; Humans; Imidazoles; In Vitro Techniques; Male; Pentanoic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane-A Synthase | 1991 |
5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.
Topics: Animals; Aorta, Thoracic; Arachidonic Acid; Arachidonic Acids; Aspirin; Cats; Collagen; Cyclooxygenase Inhibitors; Female; Ketanserin; Male; Muscle, Smooth, Vascular; Pentanoic Acids; Platelet Activation; Pyridines; Receptors, Prostaglandin; Serotonin; Thromboxane-A Synthase | 1990 |
Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
Topics: Animals; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Epinephrine; Epoprostenol; Ergolines; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; Male; Pentanoic Acids; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin Antagonists; Thromboxane A2; Thromboxane-A Synthase | 1990 |
Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Topics: Animals; Aorta; Aspirin; Blood Platelets; Carbazoles; Coronary Thrombosis; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Guinea Pigs; Humans; Imidazoles; Male; Pentanoic Acids; Platelet Aggregation; Pyridines; Rabbits; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane-A Synthase | 1993 |
Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha.
Topics: Arachidonic Acid; Aspirin; Blood Platelets; Colforsin; Cyclic AMP; Dinoprost; Dinoprostone; Drug Interactions; Epoprostenol; Humans; Pentanoic Acids; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Pyridines; Thromboxane B2 | 1993 |
Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
Topics: Animals; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Pentanoic Acids; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Pyridines; Rabbits; Receptors, Thromboxane; Thromboxane-A Synthase | 1993 |
Thromboxane synthase regulates the migratory phenotype of human glioma cells.
Topics: Arachidonic Acids; Aspirin; Astrocytes; Benzofurans; Brain Neoplasms; Cell Adhesion; Cell Movement; Enzyme Induction; Enzyme Inhibitors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; GTP-Binding Proteins; Humans; Imidazoles; Indomethacin; Lysine; Models, Biological; Neoplasm Proteins; Neoplastic Stem Cells; Oligodendroglia; Pentanoic Acids; Phenotype; Pyridines; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Thromboxane B2; Thromboxane-A Synthase; Tumor Cells, Cultured | 1999 |